Maternal Mental Health Articles & Analysis
35 news found
Today we’d like to introduce you to Gillian Henker. Hi Gillian, we’re thrilled to have a chance to learn your story today. So, before we get into specifics, maybe you can briefly walk us through how you got to where you are today. In 2014, Gillian Henker co-founded Sisu Global, leading the company’s products and technical strategy. Henker is the primary inventor of Hemafuse ...
2021 Optina, an innovative diagnostics company leading the field of Retinal Imaging, Brain Health and Systemic Diseases Diagnostics, announced today the closing of an CA$24.8 million Series A round of funding. ...
Data from award-winning presentation at IDWeek 2021 represents the first time Ferring is showcasing the RBX2660 clinical development program as a whole, comprising the largest, most robust program ever conducted in the field of microbiome-based therapeutics for recurrent C. difficile infection (rCDI) Only gut microbiome research program with five clinical studies demonstrating consistent ...
Analysis of data from five RBX2660 prospective studies is one of only four abstracts to receive the coveted IDWeek 2021 Program Committee Choice award for outstanding scientific research. Ferring and Rebiotix will present new data showing an association between clinical outcomes and restoration of the microbiome Research from the Phase 3 PUNCH CD3 trial on the effects of RBX2660 on deadly ...
RBX2660 pivotal Phase 3 trial successfully met the primary endpoint; data presented today at Digestive Disease Week® (DDW) RBX2660 is the first microbiota-based live biotherapeutic to demonstrate efficacy as early as first recurrence of Clostridioides difficile (C. difficile) infection RBX2660 Phase 3 data add to the world’s largest and most robust clinical program ever conducted in ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Alydia Health announced today that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health. Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum ...
The collaboration aims to create standardised, stabilised live microbiota-based formulations addressing bacterial vaginosis (BV), a common vaginal infection among women of reproductive age linked to increased risk of miscarriage, problems during pregnancy and fertility issues1,2,3 The companies aim to leverage world-leading microbiome technology expertise to bring new therapeutics to this ...
On October 18. 2020. the online meeting of "Scivita Medical Navigates Medical Innovation' Scivita 4K Medical Ultra-high-definition Laparoscopy in Pediatric Surgery Seminar sponsored by Pediatric Surgery Branch of Guangdong Medical Association and undertook by Guangzhou Women and Children' s Medical Center was successfully held. The conference focused on how to effectively use endoscopy to ...
Ferring and Rebiotix, a Ferring Company, will present two oral abstracts describing translational studies of investigational microbiome-based therapeutics RBX2660 and RBX7455 for the treatment of recurrent Clostridioides difficile (C. diff) infection These data presentations strengthen the company’s leadership and scientific and clinical understanding of the two investigational ...
Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3 clinical trial for RBX2660 RBX2660 is an investigational, non-antibiotic, microbiome-based therapy, developed to reduce Clostridioides difficile (C. diff) infection recurrences CDC defines C. diff as a major burden to patients and doctors and an urgent ...
IronHealth, the healthcare professional liability and stop loss unit of Ironshore, has entered into a preferred partnership with PeriGen, a perinatal software solutions provider, offering insureds access to leading-edge obstetrics artificial intelligence systems. PeriGen’s FDA-cleared artificial intelligence (AI) tools help clinicians identify continuous clinical warning signs in ...
Enrollment completion for the first Phase 3 clinical trial in microbiome industry Largest randomized, double-blinded study, with over 300 patients enrolled aimed to demonstrate the potential benefit of RBX2660 in reducing rates of recurrent Clostridioides difficile (C. diff) infection Rebiotix intends to use the results from the Phase 3 trial to serve as the basis for licensure application to ...
A new peer-reviewed study reveals that the vast majority of U.S. infants may be suffering from a substantial deficiency in an important bacterium key to breast milk utilization and immune system development, as well as protection against gut pathogens linked to common newborn conditions such as colic and diaper rash. According to the study published today in Scientific Reports, approximately ...
Rebiotix Inc, a Ferring Pharmaceuticals company, announced today that their Chief Scientific Officer, Dr. Ken Blount, has been appointed to Karolinska Institutet’s Joint Steering Committee (JSC) of the Centre for Translation Microbiome Research (CTMR) in Stockholm, Sweden. Dr. Blount joins two colleagues from Ferring Pharmaceuticals currently serving on the JSC – Per Falk, M.D., ...
Gauss Surgical, an AI-driven healthcare technology company, raised $20 million in Series C funding from Northwell Health and SoftBank Ventures Korea, the global early-stage venture capital arm of SoftBank Group, as well as from the LS Polaris Innovation Fund and seven other leading US health systems. The proceeds of the round will be used to accelerate the adoption of its Triton platform in ...
Gauss Surgical, Inc., maker of Triton, the world’s first and only platform for real-time monitoring of surgical blood loss, today announced the close of its $12.6 million in Series B financing, bringing its total funding to $24.6 million. Providence Ventures, the investment arm of Providence Health & Services, the third largest not-for-profit health system in the United States, led the ...
The National Institutes of Health and other U.S. and Canadian partners are investing $20.9 million dollars over five years to establish seven regional research and training centers in low- and middle-income countries (LMICs). The Global Environmental and Occupational Health (GEOHealth) Hubs will consist of multidisciplinary groups of researchers and partner organizations collaborating on common ...
The world’s population will increase from today’s 7.3 billion people to 9.7 billion in 2050 and 11.2 billion at century’s end, John R. Wilmoth, the director of the United Nations (UN) Population Division, told a session focused on demographic forecasting at the 2015 Joint Statistical Meetings (JSM 2015) today in Seattle. The UN projection suggests there will not be an end to ...
In recent years, scientists have linked chemicals known as phthalates with complications of pregnancy and fetal development. Now, a study led by researchers at the University of Michigan School of Public Health sheds light on the mechanism that may be to blame. Phthalates are chemicals used to make plastic materials more flexible and can also be found in personal care products such as perfumes, ...
The GE Foundation announced today a new Commitment to Action with the Clinton Global Initiative (CGI) to expand the ImPACT (Improving Perioperative & Anesthetic Care Training) Africa program in Kenya. ImPACT Africa is a sustainable training program that aims to address maternal and infant mortality related to surgical intervention during childbirth through ongoing training of skilled ...